JP2017537934A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537934A5
JP2017537934A5 JP2017530302A JP2017530302A JP2017537934A5 JP 2017537934 A5 JP2017537934 A5 JP 2017537934A5 JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017537934 A5 JP2017537934 A5 JP 2017537934A5
Authority
JP
Japan
Prior art keywords
fibulin
fibroblast
keloid
cell
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017530302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/051187 external-priority patent/WO2016092542A1/en
Publication of JP2017537934A publication Critical patent/JP2017537934A/ja
Publication of JP2017537934A5 publication Critical patent/JP2017537934A5/ja
Pending legal-status Critical Current

Links

JP2017530302A 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用 Pending JP2017537934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462088607P 2014-12-07 2014-12-07
US62/088,607 2014-12-07
PCT/IL2015/051187 WO2016092542A1 (en) 2014-12-07 2015-12-07 Use of fibulin-5 for the treatment of keloid scars

Publications (2)

Publication Number Publication Date
JP2017537934A JP2017537934A (ja) 2017-12-21
JP2017537934A5 true JP2017537934A5 (enExample) 2019-01-24

Family

ID=56106831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017530302A Pending JP2017537934A (ja) 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用

Country Status (4)

Country Link
US (1) US20190030125A1 (enExample)
EP (1) EP3226886A4 (enExample)
JP (1) JP2017537934A (enExample)
WO (1) WO2016092542A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3312608B1 (en) * 2016-10-24 2019-10-02 Akribes Biomedical GmbH Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
JP6859363B2 (ja) * 2016-11-30 2021-04-14 株式会社 資生堂 肌特性解析方法
EP3675874B1 (en) * 2017-09-01 2023-11-29 Excel Med, LLC Pharmaceuticals composition for treating keloid and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300810A2 (hu) * 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
CA2561495A1 (en) * 2004-03-29 2005-10-06 Kyoto University Truncated dance, dance complex and method of using these
EP1860182B1 (en) * 2005-02-07 2014-05-07 Kansai Medical University Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof
US7943590B2 (en) * 2007-03-16 2011-05-17 Multi-Gene Vascular Systems Ltd. Compositions and methods for treating ophthalmic disorders
ES2523841T3 (es) * 2007-12-07 2014-12-02 Seikagaku Corporation Agente terapéutico radical para queloide y cicatriz hipertrófica
JP5839814B2 (ja) * 2010-03-17 2016-01-06 グンゼ株式会社 Ｄａｎｃｅタンパク質含有徐放基材及び該徐放基材の製造方法

Similar Documents

Publication Publication Date Title
EP4331842A3 (en) Three-dimensional lattice structures for implants
WO2014027965A8 (en) Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
AU2018256579A1 (en) Methods for preparing a skin graft
MX2019010385A (es) Dispositivos, metodos y composiciones utiles en la crio-conservacion, -almacenamiento, -transporte y aplicacion de celulas terapeuticas de mamiferos.
EP4501260A3 (en) Apparatus for tissue harvesting
BR112012030017A2 (pt) cateter-balão revestido com um agente antirrestenótico e um dispersante molecular de promoção de transporte
TN2012000067A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
WO2012068515A3 (en) Compositions and methods for hair growth
EP4474011A3 (en) High elasticity hyaluronan compositions and methods of use thereof
MX353942B (es) Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos.
MX340253B (es) Recubrimiento de aguja quirúrgica y métodos.
MX2012011543A (es) Tratamiento de sarcoidosis empleando celulas madre placentarias.
BR112013004529A8 (pt) composição termogel biocompativel, método para preparar uma composição termogel biocompativel de quitosana, método para tratar, reparar, regenerar, substituir ou trocar um tecido ou orgão dentro de um corpo mamifero ou humano e uso da composição
SG10201806020VA (en) Electroactive bioadhesive compositions
FR2958163B1 (fr) Preparation issue d'une culture in vitro de cellules dedifferencieres non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention.
JP2017530151A5 (enExample)
EP4289451A3 (en) Surgical needle coatings and methods
MY157534A (en) Composition for skin external application and functional food containing rose placenta tissue culture or extract thereof
WO2015031110A3 (en) Combination therapy to promote wound healing
WO2014110353A9 (en) Notch ligand bound biocompatible substrates and their use in bone formation
GB2541854A (en) Patterned surfaces
MX360157B (es) Uso de derivados de 2-carboxamida-cicloamino-urea en el tratamiento de enfermedades dependientes de egfr o de enfermedades que han adquirido resistencia a los agentes que tienen como objetivo los miembros de la familia egfr.
EP2898891A3 (en) Terminalia chebula and Terminalia bellerica extracts for inhibition of xanthine oxidase
EP4069119A4 (en) DEVICES, SYSTEMS AND METHODS FOR CALCULATING THE AMOUNT OF ENERGY DELIVERED TO TISSUE DURING ELECTROSURGICAL TREATMENT
BR112013006541A2 (pt) agente preventivo ou terapêutico para fibrose